Cargando…

Co-detection of SARS-CoV-2 with Secondary Respiratory Pathogen Infections

Detalles Bibliográficos
Autores principales:	Freeman, Clifford L., Miller, Nathaniel M., Bastarache, Lisa, Peterson, Josh, Self, Wesley H., Barrett, Tyler W., Ward, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Concise Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840073/ https://www.ncbi.nlm.nih.gov/pubmed/33506386 http://dx.doi.org/10.1007/s11606-020-06471-0

Ejemplares similares

Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses
por: Falk, Cassandra L., et al.
Publicado: (2023)

Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Jamal, Alainna J., et al.
Publicado: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) screening among symptom-free healthcare workers
por: Demmer, Ryan T., et al.
Publicado: (2021)

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
por: Bosserman, Rachel E., et al.
Publicado: (2022)

Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
por: Saade, Elie A., et al.
Publicado: (2022)

Atopic dermatitis is not associated with SARS-CoV-2 outcomes
por: Rakita, Uros, et al.
Publicado: (2021)

Assessing severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preparedness in US community hospitals: A forgotten entity
por: Advani, Sonali D., et al.
Publicado: (2020)

Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier
por: Shin, Kyeong Seob, et al.
Publicado: (2020)

Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study
por: Hirschwerk, David, et al.
Publicado: (2020)

Longitudinal analysis of risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hemodialysis patients and healthcare personnel in outpatient hemodialysis centers
por: Gandra, Sumanth, et al.
Publicado: (2022)

Air contamination of households versus hospital inpatient rooms occupied by severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–positive patients
por: Munoz-Price, L. Silvia, et al.
Publicado: (2021)

Impact of on-site compared to off-site testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on duration of isolation and resource utilization
por: Roberts, Andrew T., et al.
Publicado: (2020)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Mitigating healthcare staffing shortages: Should healthcare workers with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) household exposures work?
por: Blanchard, Ana C., et al.
Publicado: (2023)

A survey of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–positive healthcare providers: Household prevention measures and stress early in the pandemic
por: Otero, Sebastian, et al.
Publicado: (2021)

SARS‐CoV‐2 research using human pluripotent stem cells and organoids
por: Deguchi, Sayaka, et al.
Publicado: (2021)

Influence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccinations on cluster events among patients and staff in a tertiary-care hospital in Germany
por: Eisenmann, Michael, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020
por: Hoover, Susan E., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
por: Grant, Joseph J., et al.
Publicado: (2020)

Widespread severe acute respiratory coronavirus virus 2 (SARS-CoV-2) laboratory surveillance program to minimize asymptomatic transmission in high-risk inpatient and congregate living settings
por: Jatt, Lauren P., et al.
Publicado: (2020)

Environmental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contamination in hospital rooms during the first and third coronavirus disease 2019 (COVID-19) waves
por: Le Neindre, Killian, et al.
Publicado: (2022)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants
por: Reeves, Kimberly D., et al.
Publicado: (2022)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
por: Hunter, Benton R., et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit
por: Redmond, Sarah N., et al.
Publicado: (2020)

Impact of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination on the incidence of coronavirus disease 2019 (COVID-19) among healthcare workers at an academic medical center in Vermont
por: Noyes, Cindy D., et al.
Publicado: (2022)

Air exchanges, climate change, and severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Results from a survey of the Society of Healthcare Epidemiology of America Research Network (SRN)
por: Burnham, Jason P., et al.
Publicado: (2022)

Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings—ten Emerging Infections Program sites, April–November 2020
por: Chea, Nora, et al.
Publicado: (2022)

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
por: Lewis, Sarah S., et al.
Publicado: (2020)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE
por: Reynolds, John A, et al.
Publicado: (2023)

Continuously active disinfectant inactivates severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human coronavirus 229E two days after the disinfectant was applied and following wear exposures
por: Rutala, William A., et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
por: Kohler, Philipp P., et al.
Publicado: (2020)

Sources of exposure identified through structured interviews of healthcare workers who test positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): A prospective analysis at two teaching hospitals
por: Rhee, Chanu, et al.
Publicado: (2021)

Linking sporadic hospital clusters during a community surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) B.1.617.2 delta variant: The utility of whole-genome sequencing
por: Wee, Liang En, et al.
Publicado: (2023)

Large-scale screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among healthcare workers: Prevalence and risk factors for asymptomatic and pauci-symptomatic carriers, with emphasis on the use of personal protective equipment (PPE)
por: Rajme-López, Sandra, et al.
Publicado: (2021)

Concurrent analysis of hospital stay durations and mortality of emerging severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variants using real-time electronic health record data at a large German university hospital
por: Hazard, Derek Y., et al.
Publicado: (2023)

Comprehensive investigation of an in-hospital transmission cluster of a symptomatic SARS-CoV-2–positive physician among patients and healthcare workers in Germany
por: Wendt, Ralph, et al.
Publicado: (2020)

Should Asymptomatic and Low-Risk Individuals be Tested for SARS-CoV-2?
por: Sehgal, Ashwini R.
Publicado: (2020)

Impact of rapid Cepheid Xpert Xpress severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) testing in Detroit Medical Center hospitals during the coronavirus disease 2019 (COVID-19) pandemic
por: Meyer, Monica P., et al.
Publicado: (2022)

Mapping Inequality in SARS-CoV-2 Household Exposure and Transmission Risk in the USA
por: Reitsma, Marissa B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_femasab0tt9om7iekvcdgnbhhn